Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted pyrido[2,3-B]pyrazines as IP receptor agonists

Substituted pyrido[2,3-B]pyrazines as IP receptor agonists

US Patent 9132127 · Granted Sep 15, 2015

Estimated economic value: $48,496,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds and compositions for inhibiting the activity of HIF2-alpha and their m2025
Pyrazolyl derivatives useful as anti-cancer agents2023
Chemokine receptor binding polypeptides2022
Formylated N-heterocyclic derivatives as FGFR4 inhibitors2020
Use of ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors2019
Formylated N-heterocyclic derivatives as FGFR4 inhibitors2019
Nucleic acids encoding chemokine receptor binding polypeptides2019
Pharmaceutical combinations2018
Ring-fused bicyclic pyridyl derivatives as FGFR4 inhibitors2018
Particles of N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((4-me2017
Chemokine receptor binding polypeptides2017
IP receptor agonist heterocyclic compounds2017